COVID-19 and ECMO [COVID-19]
Research type
Research Study
Full title
Outcome of COVID-19 patients after extracorporeal membrane oxygenation
IRAS ID
284118
Contact name
Giovanni Mariscalco
Contact email
Sponsor organisation
University Hospital of Helsinki
Duration of Study in the UK
0 years, 0 months, 16 days
Research summary
This is an observational retrospective multicenter European study aiming at evaluating the outcome of COVID-19 patients affected by acute respiratory distress syndrome and supported by extracorporeal membrane oxygenation (ECMO) as rescue therapy. The beneficial role of ECMO support in this cohort of patients has not established yet, and this study will be the first attempting to address this issue in a large cohort of patients recruited from high-volume ECMO units.
REC name
London - Chelsea Research Ethics Committee
REC reference
20/HRA/2366
Date of REC Opinion
14 May 2020
REC opinion
Further Information Favourable Opinion